All Stories

  1. Complications in Cancer Associated Thrombosis patients on tinzaparin by cancer site and frailty: a pooled analysis

    Article • Blood Advances, February 2026, American Society of Hematology

    Luis Jara-Palomares

  2. A simple score to identify the sickest normotensive patients with acute pulmonary embolism

    Article • ERJ Open Research, February 2026, European Respiratory Society (ERS)

    Luis Jara-Palomares

  3. The Ottawa score for prediction of recurrent venous thromboembolism in cancer patients treated with tinzaparin: an individual patient data meta-analysis

    Article • Research and Practice in Thrombosis and Haemostasis, January 2026, Elsevier

    Luis Jara-Palomares

  4. miRNAs as Epigenetic Biomarkers for CTEPH: A case-control study towards personalized medicine

    Article • ERJ Open Research, August 2025, European Respiratory Society (ERS)

    Luis Jara-Palomares

  5. Role of Extracellular Vesicles in Chronic Post-Embolic Pulmonary Hypertension: Data from an Experimental Animal Model and Patients

    Article • Biomedicines, June 2025, MDPI AG

    Luis Jara-Palomares

  6. Regional Disparities and Trends in Venous Thromboembolism Mortality in Spain (1999–2022)

    Article • Archivos de Bronconeumología (English Edition), May 2025, Elsevier

    Luis Jara-Palomares

  7. Clinically relevant bleeding according to location of metastases in cancer-associated thrombosis

    Article • European Journal of Internal Medicine, February 2025, Elsevier

    Luis Jara-Palomares

  8. Relevance of recurrent venous thromboembolism according to location of metastasis in patients with cancer-associated thrombosis. A cohort study

    Article • Thrombosis Research, January 2025, Elsevier

    Luis Jara-Palomares

  9. Impact of Residual Vein Venous Thrombosis in Consecutive Patients with Cancer-Associated Thrombosis Treated with Tinzaparin—A Cohort Study

    Article • Cancers, October 2024, MDPI AG

    Luis Jara-Palomares

  10. Cost-effectiveness of follow-up algorithms for chronic thromboembolic pulmonary hypertension in pulmonary embolism survivors

    Article • ERJ Open Research, October 2024, European Respiratory Society (ERS)

    Luis Jara-Palomares

  11. Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID‐19 vaccine

    Article • European Journal of Clinical Investigation, September 2024, Wiley

    Luis Jara-Palomares

  12. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study

    Article • EClinicalMedicine, July 2024, Elsevier

    Luis Jara-Palomares

  13. Optimisation of detecting chronic thromboembolic pulmonary hypertension in acute pulmonary embolism survivors: the InShape IV study

    Article • European Respiratory Journal, June 2024, European Respiratory Society (ERS)

    Luis Jara-Palomares

  14. Location of metastasis and complications in patients with venous thromboembolism and cancer: a systematic review

    Article • Bleeding Thrombosis and Vascular Biology, May 2024, PAGEPress Publications

    Luis Jara-Palomares

  15. Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism

    Article • CHEST Journal, March 2024, Elsevier

    Luis Jara-Palomares

  16. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

    Article • Archivos de Bronconeumología (English Edition), March 2024, Elsevier

    Luis Jara-Palomares

  17. Age and sex differences in pulmonary embolism mortality rates in Spain from 1999 to 2021

    Article • Revista Española de Cardiología (English Edition), February 2024, Elsevier

    Luis Jara-Palomares

  18. Pulmonary embolism: a practical approach to update risk stratification and treatment decisions based on the guidelines

    Article • Expert Review of Respiratory Medicine, December 2023, Taylor & Francis

    Luis Jara-Palomares

  19. Symptom-related screening programme for early detection of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the SYSPPE study

    Article • Thorax, November 2023, BMJ

    Luis Jara-Palomares

  20. Anticoagulation and venous thromboembolism in patients aged 90 years and older: Data from the RIETE registry

    Article • Journal of the American Geriatrics Society, October 2023, Wiley

    Luis Jara-Palomares

  21. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

    Article • Research and Practice in Thrombosis and Haemostasis, October 2023, Elsevier

    Luis Jara-Palomares

  22. The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysis

    Article • EClinicalMedicine, October 2023, Elsevier

    Luis Jara-Palomares

  23. When should we involve interventional radiology in the management of acute pulmonary embolism?

    Article • Breathe, September 2023, European Respiratory Society (ERS)

    Luis Jara-Palomares

  24. Lack of Funding for Direct-Acting Oral Anticoagulants for the Treatment of Pulmonary Embolism in Spain: Why and Until When

    Article • Archivos de Bronconeumología (English Edition), August 2023, Elsevier

    Luis Jara-Palomares

  25. Prospective study to evaluate quality of life in amyotrophic lateral sclerosis

    Article • Scientific Reports, July 2023, Springer Science + Business Media

    Luis Jara-Palomares

  26. Risk factors for pulmonary embolism in lung cancer patients with lower limb deep venous thrombosis: a case-control study

    Article • Translational Lung Cancer Research, July 2023, AME Publishing Company

    Luis Jara-Palomares

  27. Comparison of long-term complications in cancer patients with incidental and acute symptomatic venous thromboembolism

    Article • Frontiers in Cardiovascular Medicine, May 2023, Frontiers

    Luis Jara-Palomares

  28. Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study

    Article • Thrombosis Research, May 2023, Elsevier

    Luis Jara-Palomares

  29. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline

    Article • Annals of Oncology, May 2023, Elsevier

    Luis Jara-Palomares

  30. Platelet RNA sequencing for cancer screening in patients with unprovoked venous thromboembolism: a prospective cohort study

    Article • Journal of Thrombosis and Haemostasis, April 2023, Elsevier

    Luis Jara-Palomares

  31. The rationale, design, and methods of a trial to evaluate the efficacy and safety of oxygen therapy in patients with intermediate-risk acute pulmonary embolism

    Article • American Heart Journal, March 2023, Elsevier

    Luis Jara-Palomares

  32. Risk of recurrent cancer-associated thrombosis after discontinuation of anticoagulant therapy

    Article • Research and Practice in Thrombosis and Haemostasis, February 2023, Elsevier

    Luis Jara-Palomares

  33. Epidemiology of Lung Cancer Mortality in Spain: Updated Information (1982–2021) and Predictions up to 2046

    Article • Respiration, January 2023, Karger Publishers

    Luis Jara-Palomares

  34. Rate of Recurrence After Discontinuing Anticoagulation Therapy in Patients With COVID-19–Associated Venous Thromboembolism

    Article • JAMA Internal Medicine, December 2022, American Medical Association (AMA)

    Luis Jara-Palomares

  35. Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day

    Article • Journal of Thrombosis and Haemostasis, October 2022, Wiley

    Professor Edeghonghon Olayemi, Luis Jara-Palomares

  36. Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism

    Article • Blood, October 2022, American Society of Hematology

    Luis Jara-Palomares

  37. Low-molecular-weight heparin beyond 12 months in patients with cancer-associated thrombosis

    Article • British Journal of Cancer, October 2022, Springer Science + Business Media

    Luis Jara-Palomares

  38. COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment

    Article • Seminars in Thrombosis and Hemostasis, October 2022, Thieme Publishing Group

    Luis Jara-Palomares

  39. Cancer Histology and Natural History of Patients with Lung Cancer and Venous Thromboembolism

    Article • Cancers, August 2022, MDPI AG

    Luis Jara-Palomares

  40. Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry

    Article • JAMA Cardiology, August 2022, American Medical Association (AMA)

    Luis Jara-Palomares

  41. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19

    Article • The Lancet Oncology, July 2022, Elsevier

    Luis Jara-Palomares

  42. Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study)

    Article • Cancers, June 2022, MDPI AG

    Luis Jara-Palomares

  43. Low‐dose apixaban in extended treatment of cancer‐associated thrombosis: Less is more?

    Article • Journal of Thrombosis and Haemostasis, May 2022, Elsevier

    Luis Jara-Palomares

  44. Effect of Prognostic Guided Management of Patients With Acute Pulmonary Embolism According to the European Society of Cardiology Risk Stratification Model

    Article • Frontiers in Cardiovascular Medicine, April 2022, Frontiers

    Luis Jara-Palomares

  45. Mechanical Behavior of Calcium Sulphate Modified with Citric Acid and with Added Carbon Fibers

    Article • Polymers, April 2022, MDPI AG

    Luis Jara-Palomares

  46. ERS International Congress 2021: highlights from the Pulmonary Vascular Diseases Assembly

    Article • ERJ Open Research, April 2022, European Respiratory Society (ERS)

    Luis Jara-Palomares

  47. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

    Article • Research and Practice in Thrombosis and Haemostasis, April 2022, Elsevier

    Luis Jara-Palomares

  48. Major bleeding in patients with pulmonary embolism presenting with syncope

    Article • European Journal of Clinical Investigation, March 2022, Wiley

    Luis Jara-Palomares

  49. Adjusted D-dimer cutoff levels to rule out pulmonary embolism in patients hospitalized for COPD exacerbation: results from the SLICE trial

    Article • Thrombosis Journal, March 2022, Springer Science + Business Media

    Luis Jara-Palomares

  50. Extended anticoagulation treatment for cancer‐associated thrombosis—Rates of recurrence and bleeding beyond 6 months: A systematic review

    Article • Journal of Thrombosis and Haemostasis, March 2022, Elsevier

    Luis Jara-Palomares

  51. Venous thromboembolism in amyotrophic lateral sclerosis. A prospective quasi-experimental study

    Article • Thrombosis Research, March 2022, Elsevier

    Luis Jara-Palomares

  52. Consenso multidisciplinar para el manejo de la tromboembolia de pulmón

    Article • Archivos de Bronconeumología (English Edition), March 2022, Elsevier

    Luis Jara-Palomares

  53. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

    Article • CHEST Journal, February 2022, Elsevier

    Luis Jara-Palomares

  54. Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on At...

    Article • European Heart Journal, December 2021, Oxford University Press (OUP)

    Luis Jara-Palomares

  55. Comment on “Severity of pulmonary embolism at initial diagnosis and long-term clinical outcomes: From the COMMAND VTE Registry”

    Article • International Journal of Cardiology, December 2021, Elsevier

    Luis Jara-Palomares

  56. The immune-neuroendocrine system in COVID-19, advanced age and rheumatic diseases

    Article • Autoimmunity Reviews, November 2021, Elsevier

    Luis Jara-Palomares

  57. PICO Questions and DELPHI Methodology for the Management of Venous Thromboembolism Associated with COVID-19

    Article • Viruses, October 2021, MDPI AG

    Luis Jara-Palomares

  58. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

    Article • Internal and Emergency Medicine, October 2021, Springer Science + Business Media

    Luis Jara-Palomares

  59. Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation

    Article • JAMA, October 2021, American Medical Association (AMA)

    Dr Pedro J Marcos, Luis Jara-Palomares

  60. Analysis of Additives in Gypsum Coatings Based on Melamine, Polycarbonate Salts, Polycarboxylate, and Polycarboxylic Acids

    Article • Coatings, September 2021, MDPI AG

    Luis Jara-Palomares

  61. First Detection and Genome Sequencing of SARS-CoV-2 Lambda (C.37) Variant in Symptomatic Domestic Cats in Lima, Peru

    Article • Frontiers in Veterinary Science, September 2021, Frontiers

    Luis Jara-Palomares

  62. Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism

    Article • Journal of the American Heart Association, September 2021, Wolters Kluwer Health

    Luis Jara-Palomares

  63. WITHDRAWN: Multidisciplinary consensus for the management of pulmonary thromboembolism

    Article • Archivos de Bronconeumología (English Edition), September 2021, Elsevier

    Luis Jara-Palomares

  64. Spanish consensus for the management of pulmonary thromboembolism

    Article • Archivos de Bronconeumología (English Edition), September 2021, Elsevier

    Luis Jara-Palomares

  65. Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolism

    Article • European Respiratory Journal, August 2021, European Respiratory Society (ERS)

    David Jimenez, Luis Jara-Palomares

  66. Bleeding risk in hospitalized patients with COVID‐19 receiving intermediate‐ or therapeutic doses of thromboprophylaxis

    Article • Journal of Thrombosis and Haemostasis, August 2021, Elsevier

    Luis Jara-Palomares

  67. Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores

    Article • TH Open, July 2021, Thieme Publishing Group

    Luis Jara-Palomares

  68. Trombosis sintomática de la vena ácigos: caso clínico y revisión de la literatura

    Article • Archivos de Bronconeumología (English Edition), July 2021, Elsevier

    Luis Jara-Palomares

  69. Timing and characteristics of venous thromboembolism after noncancer surgery

    Article • Journal of Vascular Surgery Venous and Lymphatic Disorders, July 2021, Elsevier

    Luis Jara-Palomares

  70. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

    Article • The Lancet Infectious Diseases, June 2021, Elsevier

    Jordi Carratalà, Luis Jara-Palomares

  71. Análisis de las indicaciones y complicaciones de los pacientes con enfermedad tromboembólica venosa a los que se ha colocado filtro de vena cava inferior

    Article • Archivos de Bronconeumología (English Edition), June 2021, Elsevier

    Luis Jara-Palomares

  72. Case-Control Analysis of the Impact of Anemia on Quality of Life in Patients with Cancer: A Qca Study Analysis

    Article • Cancers, May 2021, MDPI AG

    Luis Jara-Palomares

  73. Repeated Pulses of Methyl-Prednisolone in Adults Hospitalized With COVID-19 Pneumonia and Acute Respiratory Distress Syndrome: A Preliminary Before–After Study (CortiCOVID Study)

    Article • Open Respiratory Archives, April 2021, Elsevier

    Luis Jara-Palomares

  74. Association between Radiotherapy and Risk of Cancer Associated Venous Thromboembolism: A Sub-Analysis of the COMPASS—CAT Study

    Article • Cancers, March 2021, MDPI AG

    Luis Jara-Palomares

  75. Deep vein thrombosis and brain metastases. Case report and systematic review

    Article • Thrombosis Research, January 2021, Elsevier

    Luis Jara-Palomares

  76. Novel biomarkers to detect occult cancer in patients with unprovoked venous thromboembolism: Rationale and design of the PLATO-VTE study

    Article • Thrombosis Update, January 2021, Elsevier

    Luis Jara-Palomares

  77. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

    Article • Journal of Thrombosis and Haemostasis, December 2020, Wiley

    Luciano López-Jiménez, Luis Jara-Palomares

  78. Incidental vs. suspected PE in patients with cancer.

    Article • European Respiratory Journal, December 2020, European Respiratory Society (ERS)

    Juan José López-Núñez, Luis Jara-Palomares

  79. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

    Article • Thrombosis Update, December 2020, Elsevier

    Luis Jara-Palomares

  80. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

    Article • Research and Practice in Thrombosis and Haemostasis, November 2020, Wiley

    Luis Jara-Palomares

  81. Establishing diagnostic criteria and treatment of subsegmental pulmonary embolism: A Delphi analysis of experts

    Article • Research and Practice in Thrombosis and Haemostasis, November 2020, Elsevier

    Dr Alejandro Lazo-Langner, Luis Jara-Palomares

  82. Thromboprophylaxis after renal transplantation and patient risk stratification: The case of mTOR inhibitors

    Article • Thrombosis Research, November 2020, Elsevier

    Luis Jara-Palomares

  83. Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

    Article • Clinical and Translational Science, October 2020, Wiley

    Luis Jara-Palomares

  84. Documento de consenso de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR) para el seguimiento clínico post-COVID-19

    Article • Open Respiratory Archives, October 2020, Elsevier

    Luis Jara-Palomares

  85. Venous thromboembolism in solid-organ transplant recipients: findings from the RIETE registry

    Article • September 2020, European Respiratory Society (ERS)

    Alberto García-Ortega, Luis Jara-Palomares

  86. Prognostic Significance of Incidental Deep Vein Thrombosis in Patients with Cancer Presenting with Incidental Pulmonary Embolism

    Article • Cancers, August 2020, MDPI AG

    Luis Jara-Palomares

  87. Correlation between short-term air pollution exposure and unprovoked lung embolism. Prospective observational (Contamina-TEP Group)

    Article • Thrombosis Research, August 2020, Elsevier

    Luis Jara-Palomares

  88. Screening for Occult Cancer in Patients with Venous Thromboembolism: Past, Present, and Future

    Article • Hämostaseologie, July 2020, Thieme Publishing Group

    Luis Jara-Palomares

  89. Derivation and validation of a clinical prediction rule for thrombolysis-associated major bleeding in patients with acute pulmonary embolism: the BACS score

    Article • European Respiratory Journal, July 2020, European Respiratory Society (ERS)

    David Jimenez, Luis Jara-Palomares

  90. Differential biomarker profiles between unprovoked venous thromboembolism and cancer

    Article • Annals of Medicine, July 2020, Taylor & Francis

    Luis Jara-Palomares

  91. Screening for occult cancer: where are we in 2020?

    Article • Thrombosis Research, July 2020, Elsevier

    Luis Jara-Palomares

  92. Comments on the 2019 ESC guidelines on acute pulmonary embolism

    Article • Revista Española de Cardiología (English Edition), June 2020, Elsevier

    Prof HECTOR BUENO, Prof. Francisco Marin , Luis Jara-Palomares

  93. Comentarios a la guía ESC 2019 sobre embolia pulmonar aguda

    Article • Revista Española de Cardiología, June 2020, Elsevier

    Prof HECTOR BUENO, Luis Jara-Palomares

  94. Association between reperfusion therapy and outcomes in patients with acute pulmonary embolism and right heart thrombi

    Article • European Respiratory Journal, May 2020, European Respiratory Society (ERS)

    David Jimenez, Luis Jara-Palomares

  95. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

    Article • Journal of Vascular Surgery Venous and Lymphatic Disorders, May 2020, Elsevier

    Luis Jara-Palomares

  96. Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, April 2020, New England Journal of Medicine (NEJM/MMS)

    Luis Jara-Palomares

  97. Systolic blood pressure and mortality in acute symptomatic pulmonary embolism

    Article • International Journal of Cardiology, March 2020, Elsevier

    Luis Jara-Palomares

  98. Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project

    Article • Clinical and Applied Thrombosis/Hemostasis, January 2020, SAGE Publications

    Luis Jara-Palomares

  99. A Case-Control Analysis of the Impact of Venous Thromboembolic Disease on Quality of Life of Patients with Cancer: Quality of Life in Cancer (Qca) Study

    Article • Cancers, December 2019, MDPI AG

    Luis Jara-Palomares

  100. Riesgo de recurrencia tras retirada de la anticoagulación en pacientes con enfermedad tromboembólica venosa no provocada: validación externa del nomograma de Viena y del modelo predictivo DASH

    Article • Archivos de Bronconeumología (English Edition), December 2019, Elsevier

    Luis Jara-Palomares

  101. Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years

    Article • Scientific Reports, December 2019, Springer Science + Business Media

    Luis Jara-Palomares

  102. Correction to: Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism

    Article • Internal and Emergency Medicine, November 2019, Springer Science + Business Media

    MD Matteo Giorgi-Pierfranceschi, Luis Jara-Palomares

  103. Venous Thromboembolism in Patients With Autoimmune Disorders: Findings From the RIETE Registry

    Article • Angiology, October 2019, SAGE Publications

    Luis Jara-Palomares

  104. El dilema de la reducción de tratamiento en pacientes con asma moderado-grave controlados

    Article • Revista Clínica Española, October 2019, Elsevier

    Luis Jara-Palomares

  105. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

    Article • The Lancet Oncology, October 2019, Elsevier

    Luis Jara-Palomares

  106. Statin and all-cause mortality in patients receiving anticoagulant therapy for venous thromboembolism. Data from the RIETE registry

    Article • European Journal of Internal Medicine, October 2019, Elsevier

    Luis Jara-Palomares

  107. Outcome of pulmonary hypertension associated with respiratory disease

    Article • September 2019, European Respiratory Society (ERS)

    Lucilla Piccari, Luis Jara-Palomares

  108. Anti-Factor Xa levels correlate with recurrent venous thromboembolism and clinically relevant bleeding in patients receiving low-molecular-weight heparin

    Article • September 2019, European Respiratory Society (ERS)

    Luis Jara-Palomares

  109. Extended treatment of cancer-associated thrombosis

    Article • Thrombosis Research, September 2019, Elsevier

    Luis Jara-Palomares

  110. Frequency and prognostic impact of acute kidney injury in patients with acute pulmonary embolism. Data from the RIETE registry

    Article • International Journal of Cardiology, September 2019, Elsevier

    Luis Jara-Palomares

  111. D‐dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry

    Article • Journal of Internal Medicine, August 2019, Wiley

    Luis Jara-Palomares

  112. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

    Article • Orphanet Journal of Rare Diseases, August 2019, Springer Science + Business Media

    Luis Jara-Palomares

  113. Hospital volume and outcomes for acute pulmonary embolism: multinational population based cohort study

    Article • BMJ, July 2019, BMJ

    Luis Jara-Palomares

  114. Correction to: Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism

    Article • Internal and Emergency Medicine, June 2019, Springer Science + Business Media

    Luis Jara-Palomares, MD Matteo Giorgi-Pierfranceschi

  115. Prediction of early mortality in patients with cancer-associated thrombosis in the RIETE Database

    Article • International Angiology, June 2019, Edizioni Minerva Medica

    Luis Jara-Palomares

  116. Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism

    Article • Internal and Emergency Medicine, May 2019, Springer Science + Business Media

    Luis Jara-Palomares, MD Matteo Giorgi-Pierfranceschi

  117. Intermittent pneumatic compression plus pharmacological thromboprophylaxis to prevent deep vein thrombosis

    Article • Journal of Thoracic Disease, May 2019, AME Publishing Company

    Luis Jara-Palomares

  118. Venous thromboembolism in young adults: Findings from the RIETE registry

    Article • European Journal of Internal Medicine, May 2019, Elsevier

    Luis Jara-Palomares

  119. The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease

    Article • Clinical Cardiology, February 2019, Wiley

    Luis Jara-Palomares, Dr Pedro J Marcos

  120. Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry

    Article • European Respiratory Journal, February 2019, European Respiratory Society (ERS)

    Luis Jara-Palomares

  121. Relationship between type of unprovoked venous thromboembolism and cancer location: An individual patient data meta-analysis

    Article • Thrombosis Research, February 2019, Elsevier

    Luis Jara-Palomares

  122. Reply to comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'

    Article • British Journal of Cancer, January 2019, Springer Science + Business Media

    Luis Jara-Palomares

  123. Direct Oral Anticoagulants or Standard Anticoagulant Therapy in Fragile Patients with Venous Thromboembolism

    Article • TH Open, January 2019, Thieme Publishing Group

    Luis Jara-Palomares

  124. Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis

    Article • Thrombosis Research, January 2019, Elsevier

    Luis Jara-Palomares

  125. Mortality after pulmonary embolism in patients with diabetes. Findings from the RIETE registry

    Article • European Journal of Internal Medicine, January 2019, Elsevier

    Luis Jara-Palomares

  126. D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis

    Article • British Journal of Cancer, October 2018, Springer Science + Business Media

    Luis Jara-Palomares

  127. Outcomes beyond the Third Month of Anticoagulation in Patients Aged >75 Years with a First Episode of Unprovoked Venous Thromboembolism

    Article • TH Open, October 2018, Thieme Publishing Group

    Luis Jara-Palomares

  128. Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, September 2018, New England Journal of Medicine (NEJM/MMS)

    Luis Jara-Palomares, MD Matteo Giorgi-Pierfranceschi, Professor Dmitry Zateyshchikov

  129. Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry

    Article • Journal of Thrombosis and Thrombolysis, September 2018, Springer Science + Business Media

    Luis Jara-Palomares

  130. Early Use of Echocardiography in Patients With Acute Pulmonary Embolism: Findings From the RIETE Registry

    Article • Journal of the American Heart Association, September 2018, Wolters Kluwer Health

    David Jimenez, Luis Jara-Palomares

  131. Towards a precision medicine in venous thromboembolism associated to lung cancer

    Article • Journal of Thoracic Disease, September 2018, AME Publishing Company

    Luis Jara-Palomares

  132. Enfermedad tromboembólica venosa y cáncer: un reto para los clínicos

    Article • Archivos de Bronconeumología (English Edition), July 2018, Elsevier

    Luis Jara-Palomares

  133. Management appropriateness and outcomes of patients with acute pulmonary embolism

    Article • European Respiratory Journal, May 2018, European Respiratory Society (ERS)

    Luis Jara-Palomares, David Jimenez

  134. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

    Article • The American Journal of Medicine, April 2018, Elsevier

    Luis Jara-Palomares

  135. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis

    Article • Thrombosis Research, April 2018, Elsevier

    MD Matteo Giorgi-Pierfranceschi, Luis Jara-Palomares

  136. Clinical Characteristics and Outcomes of Patients with Lung Cancer and Venous Thromboembolism

    Article • TH Open, April 2018, Thieme Publishing Group

    Luis Jara-Palomares

  137. Awareness and understanding of venous thromboembolism in patients with cancer: data on 100 unselected cancer outpatients

    Article • Thrombosis Research, April 2018, Elsevier

    Luis Jara-Palomares

  138. Validation of a prognostic score for hidden cancer in unprovoked venous thromboembolism

    Article • PLOS One, March 2018, PLOS

    Luis Jara-Palomares

  139. Role of a clinical prediction score in a chronic thromboembolic pulmonary hypertension rule-out strategy

    Article • European Respiratory Journal, March 2018, European Respiratory Society (ERS)

    Luis Jara-Palomares

  140. Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism

    Article • Journal of Thrombosis and Thrombolysis, January 2018, Springer Science + Business Media

    Luis Jara-Palomares, MD Matteo Giorgi-Pierfranceschi

  141. Prevalence of dual clarithromycin and metronidazole resistance in Helicobacter pylori estimated by molecular methods in Santiago, Chile

    Article • December 2017, Cold Spring Harbor Laboratory Press

    Luis Jara-Palomares

  142. Predicting the risk of cancer after unprovoked venous thromboembolism: external validation of the RIETE score

    Article • Journal of Thrombosis and Haemostasis, October 2017, Wiley

    Luis Jara-Palomares

  143. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

    Article • Research and Practice in Thrombosis and Haemostasis, September 2017, Wiley

    MD Matteo Giorgi-Pierfranceschi, Luis Jara-Palomares

  144. Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study

    Article • Thrombosis Research, September 2017, Elsevier

    Luis Jara-Palomares

  145. Características clínicas y pronóstico de la tromboembolia pulmonar secundaria al síndrome de clase turista

    Article • Archivos de Bronconeumología (English Edition), September 2017, Elsevier

    Luis Jara-Palomares

  146. Clinical Characteristics and Prognosis of Pulmonary Embolism Caused by Economy Class Syndrome

    Article • Archivos de Bronconeumología (English Edition), September 2017, Elsevier

    Luis Jara-Palomares

  147. Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism

    Article • Annals of Internal Medicine, August 2017, American College of Physicians

    Luis Jara-Palomares

  148. Real-life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants

    Article • Clinical Pharmacology & Therapeutics, August 2017, Wiley

    MD Matteo Giorgi-Pierfranceschi, Luis Jara-Palomares

  149. Correction:Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis

    Article • BMJ Open, August 2017, BMJ

    Luis Jara-Palomares

  150. Sex Differences in Patients With Occult Cancer After Venous Thromboembolism

    Article • Clinical and Applied Thrombosis/Hemostasis, July 2017, SAGE Publications

    Luis Jara-Palomares

  151. Clinically relevant bleeding and thrombotic events in non-cirrhotic splanchnic vein thrombosis. Long-term follow up

    Article • Thrombosis Research, June 2017, Elsevier

    Luis Jara-Palomares

  152. Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis

    Article • BMJ Open, June 2017, BMJ

    Luis Jara-Palomares

  153. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

    Article • The American Journal of Medicine, May 2017, Elsevier

    Luis Jara-Palomares, MD Matteo Giorgi-Pierfranceschi

  154. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

    Article • The American Journal of Medicine, April 2017, Elsevier

    Luis Jara-Palomares, MD Matteo Giorgi-Pierfranceschi

  155. Response

    Article • CHEST Journal, March 2017, Elsevier

    Luis Jara-Palomares

  156. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

    Article • The American Journal of Medicine, March 2017, Elsevier

    Luis Jara-Palomares

  157. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

    Article • CHEST Journal, March 2017, Elsevier

    Luis Jara-Palomares, MD Matteo Giorgi-Pierfranceschi

  158. Calidad de vida en pacientes diagnosticados de embolia de pulmón aguda sintomática

    Article • Revista Clínica Española, March 2017, Elsevier

    Luis Jara-Palomares

  159. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

    Article • Journal of Vascular Surgery Venous and Lymphatic Disorders, January 2017, Elsevier

    Luis Jara-Palomares

  160. Predictors of active cancer thromboembolic outcomes

    Article • Thrombosis and Haemostasis, January 2017, Thieme Publishing Group

    MD Matteo Giorgi-Pierfranceschi, Luis Jara-Palomares

  161. Noninvasive ventilation during the weaning process in chronically critically ill patients

    Article • ERJ Open Research, October 2016, European Respiratory Society (ERS)

    Luis Jara-Palomares

  162. Unusual site thrombosis: splanchnic vein thrombosis, management in noncirrothic

    Article • September 2016, European Respiratory Society (ERS)

    Luis Jara-Palomares

  163. Search predictive factors of recurrence in venous thromboembolic disease associated with cancer after withdrawal of the anticoagulation. HISPALIS study

    Article • European Respiratory Journal, September 2016, European Respiratory Society (ERS)

    Luis Jara-Palomares

  164. Occult cancer in patients with acute venous thromboembolism: Why, when and where to investigate

    Article • September 2016, European Respiratory Society (ERS)

    Luis Jara-Palomares

  165. Treatment of venous thromboembolism in cancer patients with tinzaparin beyond 6 months. TiCAT study

    Article • September 2016, European Respiratory Society (ERS)

    Luis Jara-Palomares

  166. DVT Management and Outcome Trends, 2001 to 2014

    Article • CHEST Journal, August 2016, Elsevier

    Luis Jara-Palomares

  167. Noninvasive ventilation for severely acidotic patients in respiratory intermediate care units

    Article • BMC Pulmonary Medicine, July 2016, Springer Science + Business Media

    Luis Jara-Palomares

  168. Analysis of environmental risk factors for pulmonary embolism: A case-crossover study (2001–2013)

    Article • European Journal of Internal Medicine, June 2016, Elsevier

    Luis Jara-Palomares

  169. Management and outcomes in chronic thromboembolic pulmonary hypertension: From expert centers to a nationwide perspective

    Article • International Journal of Cardiology, January 2016, Elsevier

    Luis Jara-Palomares

  170. Trends in the Management and Outcomes of Acute Pulmonary Embolism

    Article • Journal of the American College of Cardiology, January 2016, Elsevier

    Luis Jara-Palomares

  171. Discharge Planning of Neuromuscular Patients with Noninvasive Mechanical Ventilation After Difficult Weaning from Invasive Mechanical Ventilation: From ICU to Home Care

    Article • January 2016, Springer Science + Business Media

    Luis Jara-Palomares

  172. Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE registry

    Article • Thrombosis Research, December 2015, Elsevier

    Luis Jara-Palomares

  173. High correlation between 2 flow cytometry platforms in the microparticles analysis using a new calibrated beads strategy

    Article • Translational Research, December 2015, Elsevier

    Luis Jara-Palomares

  174. Platelet Count and Major Bleeding in Patients Receiving Vitamin K Antagonists for Acute Venous Thromboembolism, Findings From Real World Clinical Practice

    Article • Medicine, November 2015, Wolters Kluwer Health

    MD Matteo Giorgi-Pierfranceschi, Luis Jara-Palomares

  175. Respiratory intermediate care units: Noninvasive ventilation for severe acidotic patients

    Article • September 2015, European Respiratory Society (ERS)

    Luis Jara-Palomares

  176. Factors associated with mortality and survival in venous thromboembolism and hidden or concurrent cancer

    Article • September 2015, European Respiratory Society (ERS)

    Luis Jara-Palomares

  177. Long-term low molecular weight heparin treatment in cancer associated venous thromboembolism patients

    Article • September 2015, European Respiratory Society (ERS)

    Luis Jara-Palomares

  178. The impact of disseminated intravascular coagulation on the outcome of cancer patients with venous thromboembolism

    Article • Blood Coagulation & Fibrinolysis, September 2015, Wolters Kluwer Health

    Luis Jara-Palomares, MD Matteo Giorgi-Pierfranceschi

  179. Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism

    Article • Medicine, August 2015, Wolters Kluwer Health

    Luis Jara-Palomares

  180. Corrigendum to ‘Rivaroxaban for the treatment of venous thromboembolism. A “real-life” perspective in 103 patients’ [Thrombosis Research 134 (2014) 617–621]

    Article • Thrombosis Research, July 2015, Elsevier

    Luis Jara-Palomares

  181. A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis

    Article • Journal of Vascular Surgery Venous and Lymphatic Disorders, July 2015, Elsevier

    Luis Jara-Palomares

  182. Identification of Low-Risk Patients with Acute Symptomatic Pulmonary Embolism for Outpatient Therapy

    Article • Annals of the American Thoracic Society, June 2015, American Thoracic Society

    Luis Jara-Palomares

  183. A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the upper extremity

    Article • Journal of Thrombosis and Haemostasis, June 2015, Wiley

    Luis Jara-Palomares

  184. Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism

    Article • Journal of Vascular Surgery Venous and Lymphatic Disorders, April 2015, Elsevier

    Luis Jara-Palomares

  185. Venous thromboembolism in patients immobilised at home

    Article • European Respiratory Journal, March 2015, European Respiratory Society (ERS)

    Luis Jara-Palomares

  186. Short-term clinical outcome of normotensive patients with acute PE and high plasma lactate

    Article • Thorax, February 2015, BMJ

    Luis Jara-Palomares

  187. Fondaparinux in the initial and long-term treatment of venous thromboembolism

    Article • Thrombosis Research, February 2015, Elsevier

    Dr Raffaele Pesavento, Luis Jara-Palomares

  188. Gender differences in cancer patients with acute venous thromboembolism

    Article • Thrombosis Research, February 2015, Elsevier

    Luis Jara-Palomares

  189. Lights and shadows of non-invasive mechanical ventilation for chronic obstructive pulmonary disease (COPD) exacerbations

    Article • Annals of Thoracic Medicine, January 2015, Medknow

    Jose Luis Lopez-Campos, Luis Jara-Palomares

  190. A Prognostic Score to Identify Low-risk Outpatients with Acute Deep Vein Thrombosis in the Lower Limbs

    Article • The American Journal of Medicine, January 2015, Elsevier

    Luis Jara-Palomares

  191. Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy

    Article • European Journal of Internal Medicine, November 2014, Elsevier

    Luis Jara-Palomares

  192. Rivaroxaban for the treatment of venous thromboembolism. A “real-life” perspective in 103 patients

    Article • Thrombosis Research, September 2014, Elsevier

    Luis Jara-Palomares

  193. Outcomes in Neurosurgical Patients Who Develop Venous Thromboembolism

    Article • Clinical and Applied Thrombosis/Hemostasis, May 2014, SAGE Publications

    Luis Jara-Palomares

  194. C0396: Thrombophilia in Thrombosis and Cancer

    Article • Thrombosis Research, May 2014, Elsevier

    Luis Jara-Palomares

  195. C0211: Prevalence of Metabolic Syndrome and All-Causes Mortality in Patients with Acute Symptomatic Venous Thromboembolism (VTE)

    Article • Thrombosis Research, May 2014, Elsevier

    Luis Jara-Palomares

  196. C0246: Quality of Life in Acute Symptomatic Pulmonary Embolism and Low-Risk Prognosis

    Article • Thrombosis Research, May 2014, Elsevier

    Luis Jara-Palomares

  197. C0306: Rivaroxaban for Treatment of Venous Thromboembolism. A Real-Life Perspective in 103 Patients

    Article • Thrombosis Research, May 2014, Elsevier

    Luis Jara-Palomares

  198. D-dimer levels and 90-day outcome in patients with acute pulmonary embolism with or without cancer

    Article • Thrombosis Research, March 2014, Elsevier

    Luis Jara-Palomares

  199. Pulmonary Embolism and Concomitant Paradoxical Embolism. A Case Report

    Article • Archivos de Bronconeumología (English Edition), March 2014, Elsevier

    Luis Jara-Palomares

  200. Tromboembolismo pulmonar y embolia paradójica concomitante. A propósito de un caso

    Article • Archivos de Bronconeumología (English Edition), March 2014, Elsevier

    Luis Jara-Palomares

  201. Consenso nacional sobre el diagnóstico, estratificación de riesgo y tratamiento de los pacientes con tromboembolia pulmonar

    Article • Archivos de Bronconeumología (English Edition), December 2013, Elsevier

    Luis Jara-Palomares

  202. La escala predictiva de Khorana en pacientes con enfermedad tromboembólica venosa y cáncer

    Article • Medicina Clínica, December 2013, Elsevier

    Luis Jara-Palomares

  203. Validación de 2 escalas clínicas pronósticas en pacientes con tromboembolia pulmonar aguda sintomática

    Article • Archivos de Bronconeumología (English Edition), October 2013, Elsevier

    Luis Jara-Palomares

  204. Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism

    Article • Thrombosis Research, August 2013, Elsevier

    Luis Jara-Palomares

  205. Normativa sobre el manejo de las complicaciones respiratorias de los pacientes con enfermedad neuromuscular

    Article • Archivos de Bronconeumología (English Edition), July 2013, Elsevier

    Luis Jara-Palomares

  206. Factors Associated with elevated Pulmonary Arterial Pressure Levels on the Echocardiographic Assessment in Patients with Prior Pulmonary Embolism

    Article • Thrombosis Research, May 2013, Elsevier

    Luis Jara-Palomares

  207. Hipertensión pulmonar tromboembólica crónica

    Article • Cardiocore, April 2013, Elsevier

    Luis Jara-Palomares

  208. Clinical Manifestations of Sarcoidosis

    Article • March 2013, IntechOpen

    Luis Jara-Palomares

  209. Platelet count and outcome in patients with acute venous thromboembolism

    Article • Thrombosis and Haemostasis, January 2013, Schattauer GmbH

    Luis Jara-Palomares

  210. Análisis de 3 métodos para determinar el dímero D en pacientes con sospecha de trombosis venosa profunda

    Article • Revista Clínica Española, May 2012, Elsevier

    Luis Jara-Palomares

  211. Control ambulatorio de los pacientes con trombosis venosa profunda y cáncer: estudio de seguridad, costes e impacto presupuestario

    Article • Medicina Clínica, April 2012, Elsevier

    Luis Jara-Palomares

  212. Chronic Thromboembolic Pulmonary Hypertension Due to Upper-Extremity Deep Vein Thrombosis Caused Thoracic Outlet Syndrome

    Article • Archivos de Bronconeumología (English Edition), February 2012, Elsevier

    Luis Jara-Palomares

  213. Hipertensión pulmonar tromboembólica crónica debida a trombosis venosa profunda de miembro superior por síndrome del desfiladero torácico

    Article • Archivos de Bronconeumología (English Edition), February 2012, Elsevier

    Luis Jara-Palomares

  214. Updated Guidelines for the Treatment of Pulmonary Sarcoidosis

    Article • October 2011, IntechOpen

    Luis Jara-Palomares

  215. Effects of long-term anticoagulant therapy on levels of circulating microparticles in patients with deep venous thrombosis

    Article • Blood Coagulation & Fibrinolysis, October 2011, Wolters Kluwer Health

    Luis Jara-Palomares

  216. Malformaciones de la vena cava inferior como causa de trombosis venosa profunda. A propósito de dos casos

    Article • Revista Clínica Española, October 2011, Elsevier

    Luis Jara-Palomares

  217. Dyslipidemia as a long-term marker for survival in pulmonary embolism

    Article • Revista Portuguesa de Pneumologia, September 2011, Elsevier

    Luis Jara-Palomares

  218. Lung cancer mortality in Spain: estimating the future burden to the year 2028

    Article • The International Journal of Tuberculosis and Lung Disease, August 2011, International Union Against Tuberculosis and Lung Disease

    Luis Jara-Palomares

  219. Gender differences in lung cancer mortality trends in Andalusia 1975–2008: a joinpoint regression analysis

    Article • Medical Oncology, June 2011, Springer Science + Business Media

    Luis Jara-Palomares

  220. Echocardiographic assessment of pulmonary arterial pressure in the follow-up of patients with pulmonary embolism

    Article • Thrombosis Research, April 2011, Elsevier

    Luis Jara-Palomares

  221. Right Atrium Mass in a 28-Year-Old Patient with Pulmonary Embolism Taking Contraceptives

    Article • Journal of Atherosclerosis and Thrombosis, January 2011, Japan Atherosclerosis Society

    Luis Jara-Palomares

  222. Utility of high-resolution computed tomography and BAL in cryptogenic organizing pneumonia

    Article • Respiratory Medicine, November 2010, Elsevier

    Luis Jara-Palomares

  223. Testing for occult cancer in patients with pulmonary embolism: Results from a screening program and a two-year follow-up survey

    Article • Thrombosis Research, January 2010, Elsevier

    Luis Jara-Palomares

  224. Hallazgos en el lavado broncoalveolar de pacientes con enfermedad pulmonar intersticial difusa. Estudio de una cohorte prospectiva de 562 pacientes

    Article • Archivos de Bronconeumología (English Edition), March 2009, Elsevier

    Luis Jara-Palomares

  225. Hemorragia pulmonar por capilaritis pauciinmunitaria aislada con anticuerpos anticitoplasma de los neutrófilos negativos

    Article • Medicina Clínica, June 2008, Elsevier

    Luis Jara-Palomares

  226. Síndrome hepatopulmonar en pacientes con hepatopatía avanzada: estudio de 24 casos

    Article • Medicina Clínica, January 2008, Elsevier

    Israel Grilo Bensusan, Luis Jara-Palomares

  227. Infección por Aspergillus terreus en pacientes con EPOC en tratamiento con corticoides. A propósito de tres casos

    Article • Enfermedades Infecciosas y Microbiología Clínica, July 2007, Elsevier

    Luis Jara-Palomares

  228. Hemorragia digestiva baja asociada a celecoxib

    Article • Anales de Medicina Interna, September 2003, Instituto de Salud Carlos III/BNCS/SciELO Espana

    Luis Jara-Palomares